IN VITRO METHOD FOR THE IDENTIFICATION AND EARLY IDENTIFICATION AND FOR THE CONCOMITANT MONITORING OF THE THERAPY OF DRUG-AND ADDICTIVE SUBSTANCE-INDUCED LIVER DAMAGE

摘要

Disclosed is an in vitro method for the identification and the concomitant monitoring of the therapy and cure of drug-induced or addictive substance-induced liver damage, in which the occurrence of the human enzyme carbamoyl synthase 1 (CPS 1) or its concentration is determined in serum or plasma samples from patients who are being or have been treated with potentially liver-damaging drugs, or from people who take harmful stimulants and addictive substances or are exposed to hepatotoxic substances.